Loading...
ROCO
4747
Market cap82mUSD
Nov 13, Last price  
64.10TWD
Name

Johnson Chemical Pharmaceutical Works Co Ltd

Chart & Performance

D1W1MN
ROCO:4747 chart
P/E
30.49
P/S
4.20
EPS
2.10
Div Yield, %
2.34%
Shrs. gr., 5y
Rev. gr., 5y
2.27%
Revenues
611m
+0.78%
424,015,000411,491,000494,671,000606,711,000611,415,000
Net income
84m
+5.55%
63,561,00049,099,00064,851,00079,700,00084,123,000
CFO
63m
-54.09%
071,773,00052,347,00089,685,000136,950,00062,877,000
Dividend
Jun 21, 20241.4984 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was incorporated in 1959 and is based in New Taipei City, Taiwan.
IPO date
Jan 08, 2010
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT